
-
Trump says new tariff deadline 'not 100 percent firm'
-
Trump hosts Netanyahu in push for Gaza deal
-
Alpha males are rare among our fellow primates: scientists
-
At least 10 dead in Kenya during protests after heavy police deployment
-
Alcaraz, Sabalenka headline action in Wimbledon quarter-finals
-
Trump unveils first wave of steeper US tariffs, extends deadline
-
Knicks hire two-time NBA Coach of the Year Brown to guide club
-
Medical groups sue US health secretary over Covid-19 vaccine change
-
Now 48, man becomes 140th 'stolen grandchild' tracked in Argentina
-
Sinner wins Wimbledon reprieve after Dimitrov injury heartbreak, Djokovic survives
-
Trump unveils first wave of steeper US tariffs in push for deals
-
Swiss MLS goalie Frei resting at home after on-field collision
-
Relentless Spain reach Euro 2025 quarters after thumping Belgium
-
US stocks retreat from records on Trump tariff deluge
-
MLB Nationals name Cairo interim manager after shake-up
-
Sinner into Wimbledon quarter-finals after injury heartbreak for Dimitrov
-
Pacers guard Haliburton will miss entire '25-26 NBA season
-
Texas floods: How geography, climate and policy failures collided
-
Sinner into Wimbledon quarters after injured Dimitrov retires
-
UN General Assembly condemns 'systematic oppression' of women in Afghanistan
-
Epstein died by suicide, did not have 'client list': govt memo
-
Trump, Brazil's Lula clash over politically charged coup trial
-
Trump to meet Netanyahu in push for Gaza deal
-
Swiatek into Wimbledon quarter-finals
-
High-speed fall forces Philipsen out of Tour de France
-
Trump says to slap allies Japan, South Korea with 25% tariffs
-
Maresca shrugs off heat concerns as Chelsea face 'ugly duckling' Fluminense
-
Youth camp confirms 27 dead as Texas flood toll passes 90
-
US revoking 'terrorist' designation for Syria's HTS
-
Trump threatens allies Japan, South Korea with 25% tariffs
-
Relentless Spain thump Belgium to close in on Euro 2025 quarters
-
Wimbledon changes line-calling system after embarrassing blunder
-
France backs returning colonial-era 'talking drum' to I.Coast
-
King hails 'spirit of unity' as Britain remembers 7/7 attacks
-
US measles epidemic its worst of 21st century
-
Djokovic survives scare to reach Wimbledon quarters, Sinner in action
-
Looted art: the battle for looted treasures
-
Trump slaps allies Japan, South Korea with 25% tariffs
-
Belgian Merlier wins crash-marred Tour de France dash to Dunkirk
-
Celebs light up Schiaparelli to open Paris Haute Couture Week
-
Youth camp confirms 27 dead as Texas flood toll nears 90
-
Respect for Lara stops Mulder short of world Test record
-
Mexico president slams xenophobia after anti-gentrification protest
-
Djokovic stays on track for Wimbledon glory under Federer gaze
-
Belgian Merlier wins crash-marred Tour de France stage
-
Djokovic battles back against De Minaur to stay on track for Wimbledon glory
-
Israel, Hamas hold indirect talks ahead of Netanyahu-Trump meet
-
Trump steps up pressure for deals as US tariff deadline nears
-
Iran president says Israel attempted to assassinate him
-
Russia says minister fired by Putin killed himself

New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
O.Karlsson--AMWN